Radius Health to Release Fourth Quarter and Full Year 2021 Financial Results, Host Conference Call and Live Webcast on Thursday, February 24, 2022

Rhea-AI Summary

Radius Health, Inc. (NASDAQ: RDUS) will release its fourth quarter and full year 2021 financial results on February 24, 2022. Following the announcement, the company will host a conference call at 8:30 a.m. ET to discuss results and provide updates. Interested parties can join via dial-in or webcast. A replay of the call will be available starting on February 24 at 11:30 a.m. ET through March 3. Radius Health focuses on biopharmaceuticals in bone health, neuroscience, and oncology.

Positive

• Scheduled release of fourth quarter and full year 2021 financial results
• Opportunity for investors to engage during the conference call for insights
• Focus on addressing unmet medical needs in critical health areas

Negative

• None.

BOSTON, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (NASDAQ: RDUS) announced today that it will release its fourth quarter and full year 2021 financial results on Thursday, February 24, 2022. The Company will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the results and provide a company update.

Conference Call Information:
Domestic Dial-In Number: 1 (866) 323-7965
International Dial-In Number: 1 (346) 406-0961
Conference ID: 7696052
Webcast Link: https://edge.media-server.com/mmc/p/syvxxq83

A replay of the conference call will be available on February 24 at 11:30 a.m. ET through March 3. A live audio webcast of the call will be archived on the Company's website for 12 months. To access the replay, dial (855) 859-2056 or (404) 537-3406 for International, using conference ID number 7696052. The live audio webcast of the call can be accessed from the Investors section of the Company’s website, https://ir.radiuspharm.com/events-and-presentations. The full text of the announcement and financial results will also be available on the Company’s website.

About Radius

Radius Health is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, neuroscience, and oncology. Our team works collaboratively and relentlessly to advance our therapies; all with the goal of improving the lives of patients, their families, and their caregivers. The Radius portfolio consists of commercial and clinical development assets, including early to late-stage drug candidates. Find out more at www.radiuspharm.com.

Investor & Media Relations Contact:
Ethan Holdaway
Email: investor-relations@radiuspharm.com
Phone: (617) 583-2017

FAQ

When will Radius Health release its fourth quarter 2021 financial results?

Radius Health will release its fourth quarter 2021 financial results on February 24, 2022.

What time is the Radius Health conference call on February 24, 2022?

The conference call will take place at 8:30 a.m. ET on February 24, 2022.

How can I access the replay of the Radius Health conference call?

The replay can be accessed by dialing (855) 859-2056 or (404) 537-3406 using conference ID 7696052, starting February 24 at 11:30 a.m. ET until March 3.

What areas does Radius Health focus on in its biopharmaceutical development?

Radius Health is focused on addressing unmet medical needs in the areas of bone health, neuroscience, and oncology.